Since the abnormal expression or dysfunction of SMYD2 is often closely associated with a variety of diseases, SMYD2 is regarded as a promising candidate for the treatment of diseases, such as cardiovascular disease and cancer [12]. The gene discussed is SMYD2; the disease is cancer.